# Montelukast Sodium

NDC: 62175-204
Generic name: Montelukast Sodium
Labeler / Manufacturer: Lannett Company, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, CHEWABLE
Routes: ORAL
Marketing started: 20120803

FDA application: ANDA200405

## Active ingredients

- MONTELUKAST SODIUM: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62175-204"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62175-204
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c43d1edb-c162-4317-9a89-d84e4eff5512